2-218401663-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021198.3(CTDSP1):c.167C>T(p.Ala56Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000261 in 1,609,612 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A56T) has been classified as Likely benign.
Frequency
Consequence
NM_021198.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTDSP1 | NM_021198.3 | c.167C>T | p.Ala56Val | missense_variant | 2/7 | ENST00000273062.7 | NP_067021.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTDSP1 | ENST00000273062.7 | c.167C>T | p.Ala56Val | missense_variant | 2/7 | 1 | NM_021198.3 | ENSP00000273062 | P3 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152224Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000366 AC: 9AN: 246238Hom.: 0 AF XY: 0.0000225 AC XY: 3AN XY: 133350
GnomAD4 exome AF: 0.0000124 AC: 18AN: 1457270Hom.: 0 Cov.: 32 AF XY: 0.00000828 AC XY: 6AN XY: 724886
GnomAD4 genome AF: 0.000158 AC: 24AN: 152342Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 14, 2024 | The c.167C>T (p.A56V) alteration is located in exon 2 (coding exon 2) of the CTDSP1 gene. This alteration results from a C to T substitution at nucleotide position 167, causing the alanine (A) at amino acid position 56 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at